Europe's Top 5 Medical Device Companies to Watch in 2023.pdfinsightscare
The latest edition of Insights Care, Europe’s Top 5 Medical Device Companies to Watch in 2023, sheds light on the prominent leader, John O’Dea, CEO of Palliare.
A review of the health sensor market estimated at 400M devices and worth $4B by 2014, including 36 companies offering devices across the wellness, chronic, diagnostic and monitoring markets. Purchase the report here: https://gumroad.com/l/Khrd
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
The 10 Most Trustworthy Healthcare and Life Science solution providers” project. In this project we are presenting you some of the prominent companies and healthcare solution providers, who have very skillfully integrated technology into their daily functioning, services and products.
Digital Transformation—Spotlight on the Hospital: Jonathan Melnick, Lux Resea...Jill Gilbert
Digital Transformation is upending nearly every industry. Take automotive, for example, where long-standing companies are coming under siege as their core competencies of shaping and assembling steel no longer differentiate and instead digital solutions like infotainment and autonomy do. As this transformation makes further inroads in healthcare, we will look at what happens to the hospital, the departments that power it, and the medical devices used within it as accurate sensing, patient engagement, and data analytics become as important to efficient and effective health as traditional medical system and disease knowledge.
Startup Health creert een eigen categorie business incubators. In 10 jaar tijd wil zij 1.000 startup wereldwijd verbinden aan de uitdaging om de gezondheidszorg dramatisch te vernieuwen. Een waar 'Global Entrepreneurship' aanpak, die het ambitieniveau van Amerikaanse ondernemers weergeeft.
Da Vinci was Wrong! The future of healthcare market researchBorderless Access
Traditionally, healthcare market research has been a complex market research segment due to the inherently sensitive nature of the healthcare field. This makes conducting research a difficult, time consuming and expensive affair.
The times are changing, however. Virtual reality (VR) or mixed reality (MR) has the potential to dramatically improve how market research is conducted in the healthcare field. Imagine a VR-enabled future where researchers and respondents never have to leave the comfort of their own home or office.
Recent technological advances and the innovative approach of some of the worlds’ biggest tech companies have made VR practical as well as significantly more accessible than before. Google Cardboard is an excellent example.
Implementation of the technology in the healthcare market research field could push it forward by leaps and bounds. Think real-time access of patient and doctor interactions to researchers or the first-person view of a new medical tool through novel usage of VR as well as AR and live-streaming capabilities.
This can be further complemented with the use of health monitoring wearables, which can enhance data collection methods when utilized along with supplementary assets such as physician notes, web searches, online healthcare purchases, social media, etc.
Yet another recent development presents opportunities hitherto unavailable to researchers. The passage of the 21st Century Cures Act in 2016 could entirely alter the healthcare market research landscape. The act necessitates federal agencies and healthcare providers to electronically maintain data pertaining to healthcare as well as develop treatments and drugs by considering patient perspectives.
Access to this massive respondent-approved or patient/doctor approved dataset will make traditional dataset come to life and result in quicker and much deeper insight gathering.
With a focus on offering easy access to healthcare professionals through data centralization, Borderless Access’ advanced analytics-driven programmatic sampling suite ‘HealthSight’, is cleverly designed to streamline the process of healthcare market research keeping in mind the future of healthcare market research.
The 10 most innovative medical devices companies 2018insightscare
Despite these challenges, medical device companies have always been adept with the latest technology and innovations happening in the sector. Keeping this in mind, we bring you the in-depth profiles of- “The 10 Most Innovative Medical Devices Companies 2018.”
Presented at the 32th Naval Medical Department Academic Conference: Medical Challenges in Disruptive Era, Naval Medical Department, Chonburi, Thailand on September 5, 2019
Top 10 fastest growing healthcare tech companies 2021insightscare
Top 10 Fastest-Growing Healthcare TechCompanies, 2021 brings to your desk a listing of innovative companies striving to design & deliver cutting-edge products & solutions.
Europe's Top 5 Medical Device Companies to Watch in 2023.pdfinsightscare
The latest edition of Insights Care, Europe’s Top 5 Medical Device Companies to Watch in 2023, sheds light on the prominent leader, John O’Dea, CEO of Palliare.
A review of the health sensor market estimated at 400M devices and worth $4B by 2014, including 36 companies offering devices across the wellness, chronic, diagnostic and monitoring markets. Purchase the report here: https://gumroad.com/l/Khrd
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
The 10 Most Trustworthy Healthcare and Life Science solution providers” project. In this project we are presenting you some of the prominent companies and healthcare solution providers, who have very skillfully integrated technology into their daily functioning, services and products.
Digital Transformation—Spotlight on the Hospital: Jonathan Melnick, Lux Resea...Jill Gilbert
Digital Transformation is upending nearly every industry. Take automotive, for example, where long-standing companies are coming under siege as their core competencies of shaping and assembling steel no longer differentiate and instead digital solutions like infotainment and autonomy do. As this transformation makes further inroads in healthcare, we will look at what happens to the hospital, the departments that power it, and the medical devices used within it as accurate sensing, patient engagement, and data analytics become as important to efficient and effective health as traditional medical system and disease knowledge.
Startup Health creert een eigen categorie business incubators. In 10 jaar tijd wil zij 1.000 startup wereldwijd verbinden aan de uitdaging om de gezondheidszorg dramatisch te vernieuwen. Een waar 'Global Entrepreneurship' aanpak, die het ambitieniveau van Amerikaanse ondernemers weergeeft.
Da Vinci was Wrong! The future of healthcare market researchBorderless Access
Traditionally, healthcare market research has been a complex market research segment due to the inherently sensitive nature of the healthcare field. This makes conducting research a difficult, time consuming and expensive affair.
The times are changing, however. Virtual reality (VR) or mixed reality (MR) has the potential to dramatically improve how market research is conducted in the healthcare field. Imagine a VR-enabled future where researchers and respondents never have to leave the comfort of their own home or office.
Recent technological advances and the innovative approach of some of the worlds’ biggest tech companies have made VR practical as well as significantly more accessible than before. Google Cardboard is an excellent example.
Implementation of the technology in the healthcare market research field could push it forward by leaps and bounds. Think real-time access of patient and doctor interactions to researchers or the first-person view of a new medical tool through novel usage of VR as well as AR and live-streaming capabilities.
This can be further complemented with the use of health monitoring wearables, which can enhance data collection methods when utilized along with supplementary assets such as physician notes, web searches, online healthcare purchases, social media, etc.
Yet another recent development presents opportunities hitherto unavailable to researchers. The passage of the 21st Century Cures Act in 2016 could entirely alter the healthcare market research landscape. The act necessitates federal agencies and healthcare providers to electronically maintain data pertaining to healthcare as well as develop treatments and drugs by considering patient perspectives.
Access to this massive respondent-approved or patient/doctor approved dataset will make traditional dataset come to life and result in quicker and much deeper insight gathering.
With a focus on offering easy access to healthcare professionals through data centralization, Borderless Access’ advanced analytics-driven programmatic sampling suite ‘HealthSight’, is cleverly designed to streamline the process of healthcare market research keeping in mind the future of healthcare market research.
The 10 most innovative medical devices companies 2018insightscare
Despite these challenges, medical device companies have always been adept with the latest technology and innovations happening in the sector. Keeping this in mind, we bring you the in-depth profiles of- “The 10 Most Innovative Medical Devices Companies 2018.”
Presented at the 32th Naval Medical Department Academic Conference: Medical Challenges in Disruptive Era, Naval Medical Department, Chonburi, Thailand on September 5, 2019
Top 10 fastest growing healthcare tech companies 2021insightscare
Top 10 Fastest-Growing Healthcare TechCompanies, 2021 brings to your desk a listing of innovative companies striving to design & deliver cutting-edge products & solutions.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
2. Smartest Vendor Action Taken
Allscripts acquires Practice Fusion
Cerner convinces the VA to choose its system
without bidding
EClinicalWorks steps up its game after settling
with the DOJ
Epic releases product versions for small hospitals
4. Smartest Vendor Action Taken
Cerner convinces the VA to
choose its system without bidding
2017 Winner: McKesson plans its exit from healthcare IT
2016 Winner: Cerner partners with Leidos for the DoD bid
5. Stupidest Vendor Action Taken
EClinicalWorks is accused of falsifying EMR
certification data
Allscripts gets involved with Patrick Soon-Shiong
Cerner sues UIC after it chooses Epic
Allscripts buys McKesson’s HIT assets
Cerner acts as its own prime contractor with the
VA
7. Stupidest Vendor Action Taken
EClinicalWorks is accused of
falsifying EMR certification
data
2017 Winner: Everything done by Theranos
2016 Winner: Cerner requires employees to sign an arbitration
agreement to get future raises
8. Best Healthcare IT Vendor or
Consulting Firm
Cerner
Epic
Divurgent
Nordic
31. When ______ Talks,
People Listen
John Halamka, BIDMC
2017 Winner: John Halamka, BIDMC
2016 Winner: John Halamka, BIDMC
32. Most Effective Healthcare IT
Provider Executive
Darren Dworkin, Cedars-Sinai
John Halamka, BIDMC
David Reis, Hackensack Meridian Health
Tim Tarnowski, UMass Memorial Health Care
34. Most Effective Healthcare IT
Provider Executive
John Halamka, BIDMC
2017 Winner: John Halamka, BIDMC
2016 Winner: Marc Probst, Intermountain
35. Most Effective Medical / Clinical
Informatics Professional
Atul Butte, UCSF
Peter Embi, Regenstrief Institute
John Halamka, BIDMC
David Milov, Nemours Children’s Clinic
37. Most Effective Medical / Clinical
Informatics Professional
2017 Winner: John Halamka, BIDMC
2016 Winner: John Halamka, BIDMC
John Halamka, BIDMC
38. HIS Industry Figure with Whom You’d
Most Like to Have a Few Beers
Russ Branzell, CHIME
Jonathan Bush, Athenahealth
Judy Faulkner, Epic
Ivo Nelson, Next Wave Health
40. HIS Industry Figure with Whom You’d
Most Like to Have a Few Beers
2017 Winner: Jonathan Bush, Athenahealth
2016 Winner: Jonathan Bush, Athenahealth
Jonathan Bush, Athenahealth
41. HIS Industry Figure in Whose Face You’d
Most Like to Throw a Pie
Paul Black, Allscripts
Jonathan Bush, Athenahealth
Judy Faulkner, Epic
Girish Kumar, EClinicalWorks
Patrick Soon-Shiong, NantHealth
43. HIS Industry Figure in Whose Face You’d
Most Like to Throw a Pie
Patrick Soon-Shiong, NantHealth
2017 Winner: Elizabeth Holmes, Theranos
2016 Winner: John Hammergren, McKesson
44. HIStalk Healthcare IT
Industry Figure of the Year
Grahame Grieve, Health Intersections Pty Ltd
Steve Lieber, HIMSS (retired)
Neal Patterson, Cerner (deceased)
David Shulkin, VA
46. HIStalk Healthcare IT
Industry Figure of the Year
2017 Winner: Andy Slavitt, CMS
2016 Winner: John Halamka, BIDMC
Neal Patterson, Cerner
47. HIStalk Healthcare IT
Lifetime Achievement Award
Clem McDonald, National Library of Medicine
Terry Ragon, InterSystems
Dana Sellers, retired
Ted Shortliffe, Arizona State University
